<DOC>
	<DOC>NCT01496937</DOC>
	<brief_summary>The purpose of this exploratory first-in-human study is to evaluate the amount of GLPG0974 present in the blood (pharmacokinetics) after single oral doses of GLPG0974 given to healthy subjects. Furthermore, during the course of the study, safety and tolerability as well as the effects of GLPG0974 on mechanism of action-related parameters in the blood (pharmacodynamics) will be characterized compared to placebo.</brief_summary>
	<brief_title>First-in-Human Exploratory Single Ascending Dose of GLPG0974</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Healthy male, age 1850 years BMI between 1830 kg/m2 Any condition that might interfere with the procedures or tests in this study Drug or alcohol abuse Smoking</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>